title: Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part I.
abstract: The field of cutaneous oncology is exploding with innovative treatment options, specifically in the field of targeted therapy. These advances offer new hope to select patients with high risk skin cancers. Here we provide a two part series reviewing targeted therapy for non-melanoma skin cancer. We begin our discussion with basal cell carcinoma, moving beyond the first-in-class hedgehog inhibitors and highlighting promising clinical trials.
authors.forename: Brooke
authors.initials: B
authors.lastname: Walls
authors.forename: Laura
authors.initials: L
authors.lastname: Jordan
authors.forename: Lisa
authors.initials: L
authors.lastname: Diaz
authors.forename: Richard
authors.initials: R
authors.lastname: Miller
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000235:genetics; D002986:Clinical Trials as Topic; D003880:Dermatology / Q000639:trends; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors; D006801:Humans; D058990:Molecular Targeted Therapy; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D053823:Hedgehog Proteins